Mary1 and derivatives thereof for the treatment of mitochondrial dysfunction, vascular injury, kidney diseases, and organ aging
CA3330039A1Pending Publication Date: 2025-11-20THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3330039
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-13
- Filing Date
- 2025-05-13
- Publication Date
- 2025-11-20
Abstract
In one aspect, the disclosure relates to pyridinylpiperazine-based compound MARY1 and derivatives thereof, methods of making the same, pharmaceutical compositions comprising the same, and methods of treating acute kidney injury and reducing senescent changes in the kidney using the same. In one aspect, the disclosed compounds are selective 5-HT2B agonists. In another aspect, the disclosed compounds are useful for stimulating mitochondrial biogenesis.
Need to check novelty before this filing date? Find Prior Art
